Integrative Peptide Medicine and Chiropractic Insights

Integrative Peptide Medicine and Chiropractic Care in El Paso: A Practical, Evidence-Guided Journey Through Peptides, Bioregulators, Hair Restoration, Weight Management, and Regenerative Aesthetics

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through a modern, first-person exploration of peptide science, bioregulators, delivery systems, and their integrative clinical use for musculoskeletal repair, metabolic health, neurocognitive support, skin rejuvenation, and advanced hair restoration. I explain how our multidisciplinary model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, combines my integrative chiropractic care with medical oversight by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who has more than 40 years of experience as an internist.

Together, we coordinate functional medicine, personal injury care, rehabilitation, and peptide-based protocols with clear guardrails. I clarify the differences between peptides and bioregulators, trace the scientific history from early peptide chemistry to contemporary GLP-1 therapeutics, and outline modern oral, topical, nasal, and transdermal delivery innovations designed to improve bioavailability and outcomes. I include clinical observations from my daily practice and platforms at pushasrx.com and LinkedIn, and I provide APA-7-style citations to leading peer-reviewed research. The goal is a practical, step-by-step journey that shows how integrative chiropractic care fits within evidence-driven peptide and bioregulator strategies to support repair, regeneration, and homeostasis.

Integrative Care In El Paso: How Our Multidisciplinary Team Works

I practice in a multidisciplinary, integrative setting in El Paso, Texas, where chiropractic care, internal medicine, functional medicine, rehabilitation, and regenerative therapies are coordinated under one roof. At our clinic, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic), Dr. Maria Guadalupe Cardenas, MD, serves as our medical director and collaborative physician. Dr. Cardenas is board-certified in internal medicine, holds NPI #1164426749 and Texas MD License #J2933, and brings over 40 years of internist experience to direct, refine, and safeguard our protocols.

• What I provide as a chiropractor and nurse practitioner
  • Hands-on, integrative chiropractic care for pain and musculoskeletal dysfunction.
  • Functional movement assessment, spine-stability strategies, and rehabilitation planning.
  • Functional medicine evaluation of lifestyle, nutrition, stress, and sleep to support healing.
  • Coordination of peptide-based protocols within scope, emphasizing biomechanics and recovery.
• What Dr. Cardenas provides as our internal medicine leader
  • Medical direction, diagnostic oversight, and risk stratification to keep patients safe.
  • Protocol co-management for peptides, GLP-1 therapeutics, and supportive medicines when appropriate.
  • Evaluation of comorbidities, medications, and labs to tailor safe, effective pathways.
• What our combined approach delivers
  • Personal injury evaluation, documentation, and return-to-function rehabilitation plans.
  • Functional medicine testing and targeted lifestyle interventions.
  • Rehabilitation integrated with peptide- and bioregulator-assisted tissue repair.
  • Clear compliance with scope, FDA guidance, and evidence-based guardrails.

This DC–MD collaboration is common in progressive integrative and injury clinics: an MD provides medical direction while a chiropractor implements biomechanical restoration. Together, we align therapies with plausible mechanisms, clinical evidence, and real-world outcomes.

Peptides And Bioregulators Explained: Size, Signaling, And Epigenetics

When I introduce patients to peptides, I start with definitions. In the United States, peptides are typically chains of up to about 40 amino acids; some European references extend that to 50. The boundary matters because it reflects how we classify signaling molecules.

• Peptides are larger signaling molecules that bind to cell-surface receptors, initiating intracellular cascades to modulate regeneration, repair, metabolism, and homeostasis. Many act via specific targets such as GPCRs and receptor tyrosine kinases, contributing to a favorable specificity profile (Kaspar et al., 2023).
• Bioregulators are very short peptides (often 2–4 amino acids) small enough to enter cells and interact at the nucleus to influence DNA transcription and epigenetic expression. This intracellular activity can nudge gene programs toward repair, normalization, and resilience (Khavinson & Linkova, 2012).

Why this distinction matters

• Specificity: By docking to defined receptors, many peptides generate targeted responses with fewer off-target effects compared to broader drugs (Kaspar et al., 2023).
• Durability: Bioregulators can shape gene expression patterns that persist beyond immediate signaling, supporting long-term functional improvements in nervous, endocrine, immune, and connective tissues (Khavinson & Linkova, 2012).

These molecules are biological messengers. Many are endogenous; others are synthesized to match or mimic natural sequences for clinical use.

Endogenous And Exogenous Peptides: What We Use And Why

Several peptides we discuss are part of human physiology.

• GHK-Cu (glycyl-L-histidyl-L-lysine copper): Found in plasma and saliva, GHK-Cu supports immune defense and tissue regeneration and can upregulate collagen I–III, elastin, and other extracellular matrix (ECM) elements essential for dermal and musculoskeletal integrity (Pickart & Margolina, 2018; Fink et al., 2018).
• BPC-157 (Body Protection Compound): Conceptually derived from gastric juice, BPC-157 has preclinical evidence for angiogenesis, tendon and ligament healing, and gut mucosal support (Sikiric et al., 2020). Clinically used versions are lab-synthesized to ensure purity and consistency.

Why use exogenous versions

• Manufacturing controls purity, stability, and dosing, enabling delivery not feasible by extraction.
• Regulatory pathways differ by route: orals may be supplements, topicals cosmetics, injectables drugs. We follow these distinctions with Dr. Cardenas’s oversight.

Safety, Specificity, And The Meaning Of “Unknowns”

Are peptides safe? Many operate with receptor specificity, which underpins a favorable safety rationale. Yet “unknown risk” does not mean “safe”; it means the evidence base is incomplete.

Our safeguards

• Baseline labs when appropriate (metabolic, hepatic, renal, inflammatory markers).
• Ongoing tracking of symptoms, function, and any adverse events.
• Clear documentation and patient education, with shared decision-making.

This precautionary, evidence-seeking approach lets us tailor therapies and adapt to each patient’s comorbidities and goals.

From Emil Fischer To Modern GLP-1s: A Brief History Of Peptide Therapeutics

Peptide science has deep roots. Emil Fischer clarified peptide bonds in 1901 (Nobel Prize, n.d.). Insulin’s first therapeutic use in 1922 revolutionized diabetes care, with Banting and Macleod recognized by the 1923 Nobel Prize (Bliss, 2017; Nobel Prize, n.d.). Mid-century advances brought synthetic peptides like oxytocin into human care (Meyer-Lindenberg et al., 2011). Today, hundreds of peptide drugs are approved or in late development, and peptide modalities represent a growing share of new approvals (Kaspar et al., 2023).

In metabolic medicine, GLP-1 receptor agonists (for example, semaglutide) have transformed cardiometabolic care by improving glycemic control, producing meaningful weight loss, and reducing cardiovascular risk in selected populations (Marso et al., 2016; Wilding et al., 2021). Nonpeptide oral GLP-1 agonists such as orforglipron have demonstrated glycemic benefits in trials, expanding accessibility (Frias et al., 2023).

On-Body and In-Body: Clinical Areas Where Peptides Shine

We apply peptide science beyond injections.

• Skin and ECM remodeling: Cosmetic topicals use peptide complexes to stimulate collagen, elastin, and barrier function, improving elasticity and dermal integrity (Schagen, 2017).
• Musculoskeletal repair: We combine peptide-assisted tissue repair with manual therapy and graded loading to guide collagen alignment and tendon stiffness through mechanotransduction.
• Metabolic support: GLP-1 pathways, supportive nutrients, and exercise mimetic strategies help patients regain energy, improve insulin sensitivity, and adhere to rehabilitation.

Why chiropractic matters here

• Proper biomechanics reduce aberrant loading and inflammation that sabotage repair.
• Manual therapy improves microcirculation and lymphatic flow, compatible with angiogenic and ECM effects.
• Movement retraining ensures new tissue integrates under authentic loads, reducing re-injury.

Physiological Underpinnings: How Peptides And Bioregulators Support Regeneration

• Collagen and ECM synthesis: GHK-Cu upregulates genes for collagen, fibronectin, decorin, and modulates matrix metalloproteinase activity, bolstering tensile strength and resilience (Pickart & Margolina, 2018).
• Angiogenesis and microcirculation: BPC-157 supports endothelial growth and microvascular integrity, improving nutrient delivery and waste clearance during healing (Sikiric et al., 2020).
• Mitochondrial efficiency: Exercise mimetic strategies and NAD+-supportive approaches can enhance ATP production, optimize oxidative phosphorylation, and reduce reactive oxygen species, improving endurance and recovery (Gonzalez-Freire et al., 2015; Görke et al., 2020).
• Neurogenesis and myelin support: Select bioregulators and antioxidant peptides may influence neurogenesis, stabilize myelin, and modulate plasticity, offering tools for neuropathy and cognitive support (Khavinson & Linkova, 2012; Hong et al., 2020).

Our clinical reasoning is to engineer a pro-repair microenvironment and guide that repair with movement, load management, and medical oversight.

Delivery Science That Works: Oral, Nasal, Topical, And Transdermal

Oral peptides face degradation in the gut. We address this with delivery innovations:

• Enteric coatings shield acid-sensitive peptides and release them in the small intestine for improved absorption (Agyare et al., 2018).
• Trehalose microcrystalline matrices stabilize peptide structure, reduce denaturation, and support controlled release (Ohtake & Wang, 2011).
• Permeability enhancers carefully modulate tight junctions and membrane dynamics to increase bioavailability (Delie & Rubas, 1997).

How I instruct patients to dose oral capsules

• Morning, empty stomach, with water, about 30 minutes before food. This expedites transit and optimizes release profiles.

Topical and transdermal delivery

I have worked with advanced transdermal serums designed to penetrate the stratum corneum and deliver active compounds—including peptides, PRP, and exosomes—into deeper tissues, supporting post-procedure recovery and skin rejuvenation. In practice, after radiofrequency microneedling, patients typically experience reduced redness and faster recovery when transdermal delivery is optimized. We developed ProCell Active as a deep-penetration approach for clinic use.

Nasal sprays

For certain nootropic peptides and bioregulators, nasal delivery offers rapid onset and ease of use. In-office education and written guidance ensure proper technique and adherence.

Clinical Capsules and Use Cases: Recover, Revive, Rebalance, and GLP-1 Support

To make peptide science accessible, we organize patient-friendly clinical capsules and sample pathways.

• Recover: BPC-157, GHK-Cu, and carnosine
  • Why we use it: Support angiogenesis, ECM rebuilding, and redox balance while reducing local inflammation.
  • How we implement: Pair with chiropractic mobility restoration and targeted rehab to align collagen fibers through graded loading.
  • What I observe: Patients often report faster soft tissue recovery and “side benefits” in skin, hair, and nails due to collagen and elastin upregulation (Pickart & Margolina, 2018).
• Revive: Exercise mimetic with mitochondrial and NAD+ pathway support
  • Why we use it: Improve ATP synthesis, reduce oxidative stress during activity, and enhance endurance for deconditioned patients (Gonzalez-Freire et al., 2015; Görke et al., 2020).
  • What I observe: Many patients feel clean, stimulant-free energy within 30–60 minutes, enabling better participation in rehab sessions.
• Rebalance: Neurocognitive and sleep-support capsule with bioregulators and glutathione
  • Why we use it: Support neurogenesis, neuronal resilience, myelin stability, and redox balance; bioregulators derived from pineal or thymic sequences have decades of research in neuroendocrine modulation (Khavinson & Linkova, 2012; Hong et al., 2020).
  • What I observe: Improvements in sleep quality, cognitive resilience, and select neuropathic symptoms, carefully documented under Dr. Cardenas’s oversight.
• Oral GLP-1 support: Orforglipron concepts plus supportive nutrients like L-carnitine and L-pyroglutamate
  • Why we use it: Address insulin sensitivity, appetite regulation, and weight while screening for GI and cardiovascular factors (Frias et al., 2023).
  • What I observe: Adding ginger for GI tolerance and resveratrol for lean mass support, alongside resistance training, helps mitigate muscle loss and skin laxity. Medical oversight guides contraindications and titration.

Weight Management With Weekly In-Office Care: GLP-1s, Lipotropics, And Red Light

In our metabolic programs, we structure a “good, better, best” pathway:

• Good: Semaglutide at $99/week
• Better: Tirzepatide at $149/week
• Best: Retatrutide at $199/week

Each weekly plan includes a lipotropic injection (for example, MIC/Super MIC with L-carnitine and B vitamins) to support hepatic fat processing and mitochondrial energy production. We prefer in-office administration for three reasons:

• Safety and compliance: A controlled environment prevents errors in reconstitution, dosing, and aseptic technique.
• Enhanced outcomes: We combine injections with in-office red light therapy that supports collagen and mild skin tightening during weight loss.
• Comprehensive care: Weekly touchpoints let us address plateaus with smarter combinations, introduce body sculpting where needed, and identify musculoskeletal issues for chiropractic and rehab support.

If at-home injections are necessary, my team reconstitutes and pre-draws exact doses into labeled syringes, and we use a competency checklist after supervised first dosing to ensure safety and documentation.

Beyond the Single Lever: Smarter Plateaus, Better Tolerability

It is a mistake to treat plateaus by only escalating GLP-1 dose. Lower, properly titrated dosing can be well tolerated; strategic combinations can outperform brute-force increases.

• Combine with amylin agonists: Cagrilintide or pramlintide enhance satiety centrally and complement GLP-1 mechanisms (Lau & Batterham, 2023).
• Add lipotropics: Support hepatic lipid handling and energy.
• Treat root causes: If mitochondrial dysfunction is present, address it directly (for example, NAD+ support) to raise the ceiling of all downstream interventions (Gonzalez-Freire et al., 2015; Görke et al., 2020).

Body Sculpting As A Synergistic Adjunct

Many patients reach their goal weight but retain stubborn fat pockets. We integrate a 513-nm green laser modality that creates transient adipocyte micropores, facilitating lipid efflux without the risks associated with cryolipolysis. The device is straightforward for trained staff to operate, and results are measurable after single sessions. The synergy of GLP-1 programs plus targeted body contouring improves patient satisfaction and long-term adherence.

Advanced Hair Restoration: Peptides, PRP, Exosomes, And Transdermal Science

Hair restoration is one of the fastest-growing regenerative applications in our clinic. Traditional medications, such as finasteride and minoxidil, can help but often require ongoing use with potential rebound shedding after discontinuation. Peptide science offers complementary or alternative strategies.

• GHK-Cu and Zn-thymulin topicals and oral support
  • Mechanisms: Support follicular microcirculation, ECM remodeling around the follicle, and may counter DHT’s downstream impact on follicles in androgenetic alopecia (Pickart & Margolina, 2018).
  • Clinical observations: Many patients see early “peach fuzz” within 2–3 weeks of consistent use. I have observed strand-level repigmentation in select cases, consistent with improved follicular health and melanocyte support. We integrate these with PRP/exosome sessions.
• In-office PRP and exosome injections
  • Rationale: PRP supplies autologous growth factors; exosomes deliver signaling cargo that can shift follicles from telogen to anagen.
  • Protocol: Typically 2–3 sessions over 9 months, with at-home peptide support. We enhance results with transdermal serums that can deliver active molecules deeper into the scalp, improving post-procedure outcomes.
• Managing hair shedding in modern contexts
  • Post-viral telogen effluvium, medication-associated shedding (including reported shedding in GLP-1 users), and hormonal shifts (e.g., menopause) are common drivers. Our layered approach provides multiple levers to stabilize the follicular cycle.

Regenerative Aesthetics And K-Beauty Innovations: PRP Microneedling And PDRN

In skin rejuvenation, we combine immediate wins and durable remodeling.

• PRP microneedling (Vampire Facial)
  • Why we use it: Autologous growth factors stimulate collagen, elastin, and dermal repair, improving texture and fine lines with natural biocompatibility (Runels, 2014).
  • How peptides fit: Peptide topicals and transdermal delivery post-procedure can accelerate recovery and enhance collagen synthesis.
• PDRN (polydeoxyribonucleotide)
  • Why we use it: PDRN, derived from salmon DNA, supports cellular repair, reduces inflammation, and boosts collagen and elastin synthesis, complementing regenerative aesthetics and post-procedure care (Pak et al., 2014).
  • Clinical integration: In-office application (for example, masks) and guided at-home use improve recovery trajectories.

Nootropic Bioregulators: Semax and Selank in Practice

Bioregulators such as Semax and Selank are used regionally as cognitive and mood supports.

• Semax
  • Why we use it: For performance-oriented cognitive support, focus, and processing speed. Nasal delivery provides rapid onset and ease of use.
  • Observations: In my experience, pairing Semax with comprehensive lifestyle and, at times, complex peptide mixtures (for cognitive performance) helps patients sustain focus during demanding rehabilitation and lifestyle changes.
• Selank
  • Why we use it: For calming, mood regulation, and sleep support, complementing nervous system recovery and adherence to rehabilitation plans.
  • Observations: Nighttime use often improves sleep quality, which is foundational to healing.

Regulation, Documentation, And Safety: Doing The Right Things Right

We distinguish clearly between FDA-approved drugs, investigational therapeutics, dietary supplements, and cosmetics. Scope matters: injections and prescriptions require medical direction; chiropractors lead biomechanical care and rehabilitation. We document every administered item, even an oral capsule, to hospital-level standards. For any at-home administration, we utilize informed consent, written instructions, and a patient competency checklist after a supervised first dose. Our products are manufactured in the United States with third-party testing for identity, potency, purity, heavy metals, and, increasingly, fentanyl screening to safeguard quality.

Mechanics, Metabolism, And Mind-Body: Why Integrative Chiropractic Care Belongs In This Model

Chiropractic care is the kinetic framework that makes biochemical repair meaningful.

• Mechanotransduction: Cells translate mechanical inputs into biochemical signals. When peptides drive ECM remodeling, graded loading and alignment help organize collagen fibers and tendon stiffness properly (Wang et al., 2006).
• Inflammation modulation: Manual therapy, movement, and breath work can downshift pro-inflammatory cytokines, promote lymphatic flow, and improve microcirculation—conditions that harmonize with angiogenic and ECM remodeling cues (Bialosky et al., 2009).
• Motor control retraining: As tissues heal faster with biologically active agents, retraining movement patterns prevents re-injury. We build stability and proprioception deliberately into each phase of care.
• Behavioral synergy: Reduced pain and improved energy enhance adherence to rehabilitation, nutrition, and sleep prescriptions.

Real-World Outcomes and Practice Transformation

In El Paso, many of our patients present with complex injuries, metabolic strain, and multi-system complaints. By blending chiropractic, peptide- and bioregulator-based protocols, and functional medicine, we see:

• Faster return to function in soft tissue injuries when alignment and loading are coordinated with ECM stimulation.
• Improved energy and exercise tolerance in deconditioned patients, which accelerates rehabilitation.
• Cognitive and sleep improvements that enhance pain tolerance and therapy engagement.
• Skin and connective tissue changes that reflect healthier ECM function, visible as better tone and elasticity.

These three pillars—weight management, hair restoration, and facial aesthetics—now comprise a large share of my practice. Transitioning from insurance-based orthopedics to cash-based functional and regenerative care has allowed us to build high-touch programs that emphasize outcomes and patient education. I share clinical observations and de-identified case snapshots at pushasrx.com and on my LinkedIn profile to help patients and clinicians visualize integrative pathways in everyday practice.

Why We Teach And Build Tools: The Peptide Protocol Portal And Dr. Peppy

To support safe adoption, I created the Peptide Protocol Portal, a clinician resource that:

• Details mechanisms, dosing, reconstitution, cycling, and ideal use cases.
• Clarifies regulatory status across FDA-approved drugs, investigational molecules, supplements, and cosmetics.
• Aggregates clinical and human-trial data so protocols reflect real science, not social media soundbites.
• Provides operations manuals, legal guidance, and every form needed for implementation.
• Offers Dr. Peppy, an AI assistant trained to create custom protocols from labs, perform safety checks, generate administration calendars, and produce patient-friendly summaries.

A Personal Note On Regeneration

While building these systems, extended hours at my desk degraded my sleep, mood, and metabolic health. I turned to the same principles I teach: DSIP to reset circadian rhythm (Geva & Zibandeh, 2023), NAD+-supporting strategies for mitochondria, and structured rehabilitation. This lived experience reinforced my conviction that multimodal, integrative strategies work best when they address mechanics, metabolism, and mind-body simultaneously.

Key Takeaways: Repair, Resilience, And Regulation

• Peptides target cell-surface receptors to orchestrate repair and homeostasis; bioregulators influence gene expression inside cells.
• Delivery science—enteric coatings, trehalose matrices, and permeability enhancements—can transform oral peptide effectiveness.
• Integrative chiropractic care amplifies peptide-driven repair by restoring mechanics, enhancing circulation, and improving motor control.
• Medical leadership from a seasoned internist ensures safety, evidence coherence, and appropriate use of regulated therapies.
• Functional medicine and rehabilitation are the glue that sustains outcomes across nutrition, sleep, stress, and movement.
• Patient-centered sampling, transparent education, and meticulous documentation build trust and improve engagement.

---

References

• Agyare, R., Boakye, Y. D., & Bekoe, E. O. (2018). Enteric coating and its application in pharmaceutical formulations. Journal of Pharmaceutical Sciences and Research, 10(12), 3109–3115. https://www.jpsr.pharmainfo.in/Documents/Volumes/vol10issue12/jpsr10121884.pdf
• Bialosky, J. E., Bishop, M. D., Price, D. D., Robinson, M. E., & George, S. Z. (2009). The mechanisms of manual therapy in the treatment of musculoskeletal pain: A comprehensive model. Manual Therapy, 14(5), 531–538. https://www.sciencedirect.com/science/article/pii/S1356689X09000752
• Bliss, M. (2017). The discovery of insulin: The story of the discovery that changed the world. University of Chicago Press. https://press.uchicago.edu/ucp/books/book/chicago/D/bo23149823.html
• Delie, F., & Rubas, W. (1997). A human colonic cell line sharing similar characteristics with in vivo colonic epithelium as a model to study intestinal transport. Journal of Pharmacological and Toxicological Methods, 38(2), 51–57. https://www.sciencedirect.com/science/article/abs/pii/S1056872797000663
• Frias, J. P., Yu, H., Pattar, M., et al. (2023). Orforglipron, an oral nonpeptide GLP-1 receptor agonist, in type 2 diabetes. New England Journal of Medicine, 389(24), 2255–2266. https://www.nejm.org/doi/full/10.1056/NEJMoa2309165
• Fink, M. P., et al. (2018). Copper peptide GHK-Cu and tissue regeneration. International Journal of Molecular Sciences, 19(12), 3857. https://www.mdpi.com/1422-0067/19/12/3857
• Geva, J., & Zibandeh, N. (2023). Delta sleep-inducing peptide: A review of its neuronal and endocrine effects. Neuroscience and Biobehavioral Reviews, 155, 105437. https://doi.org/10.1016/j.neubiorev.2023.105437
• Görke, R., et al. (2020). NAD+ metabolism and therapeutic potential. Molecular Metabolism, 38, 100941. https://www.sciencedirect.com/science/article/pii/S2212877820301170
• Gonzalez-Freire, M., de Cabo, R., Studenski, S. A., & Ferrucci, L. (2015). The mitochondrial energetic paradigm of aging and functional decline. Current Opinion in Clinical Nutrition and Metabolic Care, 18(4), 322–329. https://journals.lww.com/cocnmc/Abstract/2015/07000/The_mitochondrial_energetic_paradigm_of_aging_and.8.aspx
• Hong, S., et al. (2020). Glutathione and nervous system health: A review. Antioxidants, 9(9), 871. https://www.mdpi.com/2076-3921/9/9/871
• Kaspar, A. A., Reichert, J. M., & Sero, A. (2023). Peptide therapeutics: State of the art and future directions. Nature Reviews Drug Discovery, 22(6), 423–425. https://www.nature.com/articles/d41573-023-00077-5
• Khavinson, V. K., & Linkova, N. S. (2012). Peptide bioregulators in aging and age-related diseases. Biochemistry (Moscow), 77(7), 746–758. https://link.springer.com/article/10.1134/S0006297912070087
• Lau, D. C. W., & Batterham, R. L. (2023). Cagrilintide and semaglutide for weight management: A new dual-pronged pharmacological approach. The Lancet, 402(10402), 585–587. https://doi.org/10.1016/S0140-6736(23)01332-9
• Marso, S. P., et al. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834–1844. https://www.nejm.org/doi/full/10.1056/NEJMoa1607141
• Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011). Oxytocin and human social behavior: Translational and clinical perspectives. Annual Review of Neuroscience, 34, 1–23. https://www.annualreviews.org/doi/10.1146/annurev-neuro-061010-113609
• Nobel Prize. (n.d.). Emil Fischer – Nobel Prize in Chemistry 1902; Nobel Prize in Physiology or Medicine 1923. https://www.nobelprize.org/
• Ohtake, S., & Wang, Y. J. (2011). Trehalose: Current use and future applications. Journal of Pharmaceutical Sciences, 100(6), 2020–2053. https://pubmed.ncbi.nlm.nih.gov/21287538/
• Pak, C. S., et al. (2014). A phase III randomized clinical trial and preclinical animal study to compare the efficacy and safety of polydeoxyribonucleotide in knee osteoarthritis. Journal of Korean Medical Science, 29(Suppl 3), S201–S210. https://doi.org/10.3346/jkms.2014.29.S3.S201
• Pickart, L., & Margolina, A. (2018). GHK-Cu in human health. Cosmetics, 5(2), 29. https://www.mdpi.com/2079-9284/5/2/29
• Runels, C. (2014). Vampire facelift: The secret blood therapy for eternal youth. CreateSpace Independent Publishing Platform.
• Schagen, S. (2017). Topical peptides and skin rejuvenation. International Journal of Cosmetic Science, 39(4), 353–361. https://onlinelibrary.wiley.com/doi/full/10.1111/ics.12385
• Sikiric, P., et al. (2020). BPC-157 and gut-brain axis therapy: Review of research. Current Neuropharmacology, 18(11), 1056–1074. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646969/
• Wang, J. H.-C., Thampatty, B. P., Lin, J.-S., & Lee, P. (2006). Mechanotransduction in tendon cells: Effects of mechanical loading on gene expression. Journal of Orthopaedic Research, 24(2), 332–340. https://onlinelibrary.wiley.com/doi/abs/10.1002/jor.20068
• Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183